Lysophosphatidic acid-induced aggregation of human and feline platelets: structure-activity relationship - PubMed (original) (raw)
Lysophosphatidic acid-induced aggregation of human and feline platelets: structure-activity relationship
A Tokumura et al. Biochem Biophys Res Commun. 1981.
No abstract available
Similar articles
- Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor.
Tokumura A, Yoshida J, Maruyama T, Fukuzawa K, Tsukatani H. Tokumura A, et al. Thromb Res. 1987 Apr 1;46(1):51-63. doi: 10.1016/0049-3848(87)90206-4. Thromb Res. 1987. PMID: 3647677 - Lysophosphatidic acids. II. Interaction of the effects of adenosine diphosphate and lysophosphatidic acids in dog, rabbit, and human platelets.
Gerrard JM, Kindom SE, Peterson DA, White JG. Gerrard JM, et al. Am J Pathol. 1979 Dec;97(3):531-47. Am J Pathol. 1979. PMID: 315721 Free PMC article. - Human platelet aggregation induced by 1-alkyl-lysophosphatidic acid and its analogs: a new group of phospholipid mediators?
Simon MF, Chap H, Douste-Blazy L. Simon MF, et al. Biochem Biophys Res Commun. 1982 Oct 29;108(4):1743-50. doi: 10.1016/s0006-291x(82)80113-7. Biochem Biophys Res Commun. 1982. PMID: 6924857 No abstract available. - Acetal phosphatidic acids: novel platelet aggregating agents.
Brammer JP, Maguire MH, Walaszek EJ, Wiley RA. Brammer JP, et al. Br J Pharmacol. 1983 May;79(1):157-66. doi: 10.1111/j.1476-5381.1983.tb10508.x. Br J Pharmacol. 1983. PMID: 6871540 Free PMC article. - Are lysophosphatidic acids or phosphatidic acids involved in stimulus activation coupling in platelets?
Benton AM, Gerrard JM, Michiel T, Kindom SE. Benton AM, et al. Blood. 1982 Sep;60(3):642-9. Blood. 1982. PMID: 6921047 No abstract available.
Cited by
- Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role for lysophosphatidic acid.
Watson SP, McConnell RT, Lapetina EG. Watson SP, et al. Biochem J. 1985 Nov 15;232(1):61-6. doi: 10.1042/bj2320061. Biochem J. 1985. PMID: 3853461 Free PMC article. - Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside.
Xu Y. Xu Y. Cancers (Basel). 2019 Oct 10;11(10):1523. doi: 10.3390/cancers11101523. Cancers (Basel). 2019. PMID: 31658655 Free PMC article. Review. - Therapeutic potential of autotaxin/lysophospholipase d inhibitors.
Federico L, Pamuklar Z, Smyth SS, Morris AJ. Federico L, et al. Curr Drug Targets. 2008 Aug;9(8):698-708. doi: 10.2174/138945008785132439. Curr Drug Targets. 2008. PMID: 18691016 Free PMC article. Review. - Lysophosphatidic acid induces neointima formation through PPARgamma activation.
Zhang C, Baker DL, Yasuda S, Makarova N, Balazs L, Johnson LR, Marathe GK, McIntyre TM, Xu Y, Prestwich GD, Byun HS, Bittman R, Tigyi G. Zhang C, et al. J Exp Med. 2004 Mar 15;199(6):763-74. doi: 10.1084/jem.20031619. Epub 2004 Mar 8. J Exp Med. 2004. PMID: 15007093 Free PMC article. - Increased formation of phosphatidylinositol-4-phosphate in human platelets stimulated with lysophosphatidic acid.
Mani I, Gaudette DC, Holub BJ. Mani I, et al. Lipids. 1996 Dec;31(12):1265-8. doi: 10.1007/BF02587911. Lipids. 1996. PMID: 8972459
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources